ADA 2025 20 - 23 June 2025

Changes in Clinical Measures among US Adults with Type 2 Diabetes and Chronic Kidney Disease Receiving Once-Weekly Semaglutide vs. Oral Antidiabetic Medications

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Diabetes
Chronic Kidney Disease
Congress poster
GLP-1 RA
Semaglutide
RWE HEOR